Vivek Subbiah, MD
@VivekSubbiah
Chief, Early-Phase Drug Development|@SarahCannonDocs
#Oncologist, #Phase1trials, #PrecisionMedicine. Tweets=My own.
ID:3085571050
http://rb.gy/2h7jj 11-03-2015 03:24:25
27,9K Tweets
33,9K Followers
2,2K Following
Late post: AMAZING City of Hope GU mini-retreat planned by Abhishek Tripathi. He invited the stellar Irbaz Riaz MD,MS,MBI,PhD Mayo Clinic Comprehensive Cancer Center who enlightened us re: applications of #AI in #oncology . Had a chance to show him around our beautiful campus w Hedyeh Ebrahimi & Regina Barragan-Carrillo! Tanya Dorff…
In this analysis of PRO data from the landmark LIBRETTO-001 trial published by Alexander Drilon MD Vivek Subbiah, MD Benjamin Besse Ben Solomon @keunchilpark Herbert Loong and others, the majority of patients with RET cancers that we treated remained stable or improved demonstrating the…
Sharing our editorial on Rationalizing rules for immunotherapy combination trials - Vivek Subbiah, MD
Aakash Desai, MD, MPH Sarah Cannon Docs ACS Journal Cancer American Cancer Society
oncodaily.com/blog/63699.html
#ASCO #Cancer #PrecisionMedicine #ClinicalTrials #OncoDaily #Oncology
Rationalizing rules for immunotherapy combination trials: About time for precision immunotherapy ACS Journal Cancer acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…
Interpreting and integrating genomic tests results in clinical cancer care - Vivek Subbiah, MD
CA: A Cancer Journal for Clinicians American Cancer Society Raffaella Casolino Ben Westphalen Clare Turnbull- Prof/NHS Dr Chantal Pauli Debyani Chakravarty, PhD 🇺🇦
oncodaily.com/64475.html
#ACS #Cancer #OncoDaily #Oncology
So honored to deliver the opening keynote at Stat4Onc Annual meeting! - Vivek Subbiah, MD
UConn U.S. FDA MD Anderson Cancer Center
oncodaily.com/64385.html
#OncoDaily #Oncology #Cancer #Stat4Onc #HealthCare
🚨Pleased to share our editorial 👉Ready, Set, Go: Setting Off on the Mission to Target KRAS in Colorectal Cancer | JCO Oncology Practice JCO Oncology Practice ASCO ASCOPost Journal of Clinical Oncology
ascopubs.org/doi/pdf/10.120…
🚨🥁 Hot off the press! 📰 Delighted to share our editorial in ASCO JCO Oncology Practice
🚀'Ready, Set, Go: Setting Off on the Mission to Target KRAS in Colorectal Cancer.'
⚡️Let's accelerate progress in KRAS targeting together #KRAS #CRCSM KRASKickers Fight Colorectal Cancer OncoDaily OncoAlert…
Advancing Truth in Oncology by Complementing Clinical Trials With Evidence From Clinical Practice Elad Sharon JAMA Oncology
jamanetwork.com/journals/jamao…
⭐️Picking that needle in haystack --> ROS1 fusion in Glioblastoma.
👉Striking response to entrectinib in glioblastoma harboring ROS1 fusion - nice work by Lombardi Giuseppe Marta Padovan IOV - Istituto Oncologico Veneto et al 🎯🧬🇮🇹EANO SNO #glioblastoma #precisionmedicine OncoDaily…
Facilitating a midnight session (!) on #cancer pain for 80 of Indonesia's expert oncologists and #palliativecare clinicians who've been setting aside their Saturdays to rapidly learn best practices in cancer #supportivecare ! High-quality holistic symptom management impacts second…
Authors proposed a precision-driven approach for patient selection to identify successful combinations of immunotherapy to improve outcomes for patients with cancer. Vivek Subbiah, MD #Cancer #PrecisionMedicine #immunotherapy OncoAlert OncoDaily #ASCO24
Authors proposed a precision-driven approach for patient selection to identify successful combinations of immunotherapy to improve outcomes for patients with cancer
Vivek Subbiah, MD Aakash Desai, MD, MPH #Cancer #immunotherapy OncoAlert OncoDaily #ASCO24
doi.org/10.1002/cncr.3…